Brookfield Office Properties C (BOXC) 21.89

New Post Public Reply Private Reply Replies (0) Message Board

Sep 8, 2016 at 7:05 AM

Brookfield Office Properties C (BOXC) 21.89 $BOXC

Brookfield Canada Office Properties to Hold Conference Call & Webcast of 2016 Second Quarter Financial Results Tuesday, July 26, 2016 at 9:00 AM (ET)
Marketwire Canada - Fri Jun 24, 8:00AM CDT
TORONTO, ON--(Marketwired - Jun 24, 2016) - Brookfield Canada Office Properties (TSX: BOX.UN) (NYSE: BOXC) announced today that its 2016 second quarter financial results will be released after the market close on Monday, July 25, 2016. Analysts, investors and other interested parties are invited to participate in the company's live conference call and webcast on Tuesday, July 26, 2016, at 9:00 AM (ET) to discuss with members of senior management the company's results and current business initiatives. Both the press release and the supplemental information package will be available on the website at www.brookfieldcanadareit.com.
BOX-UN.TO: 28.38 (+0.10), BOXC: 21.89 (-0.05)

Will Highwoods (HIW) Grow on Strong Operating Results?
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 6:38AM CDT
We updated our research report on Highwoods Properties Inc. (HIW) on Jun 21, 2016.
APLE: 18.60 (-0.11), COR: 81.36 (+0.42), BOXC: 21.89 (-0.05), HIW: 53.92 (+0.23)

Duke Realty (DRE) Prices Offering of $375M Senior Notes
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 6:46AM CDT
Duke Realty Corporation (DRE) has announced the pricing of a public offering of $375 million unsecured senior notes.
DRE: 28.31 (+0.01), APLE: 18.60 (-0.11), COR: 81.36 (+0.42), BOXC: 21.89 (-0.05)

Brookfield Canada Office Properties Declares July 2016 Monthly Distribution
Marketwired - Wed Jun 15, 3:30PM CDT
TORONTO, ON--(Marketwired - Jun 15, 2016) - The Board of Trustees of Brookfield Canada Office Properties (TSX: BOX.UN) (NYSE: BOXC) announced a distribution of $0.1092 per trust unit payable on July 15, 2016 to holders of Trust units of record at the close of business on June 30, 2016.
BOX-UN.TO: 28.38 (+0.10), BOXC: 21.89 (-0.05)

Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:30AM CDT
Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
APLE: 18.60 (-0.11), COR: 81.36 (+0.42), CRY: 17.64 (+1.21), MLAB: 115.08 (+0.64), BOXC: 21.89 (-0.05)

Five Recent Strong Buys In Two Industries
Brian Bolan - Zacks Investment Research - Fri Jun 10, 8:32AM CDT
Five Recent Strong Buys In Two Industries
APLE: 18.60 (-0.11), COR: 81.36 (+0.42), CRY: 17.64 (+1.21), MLAB: 115.08 (+0.64), BOXC: 21.89 (-0.05)

Cousins & Hines Ink Lease With Microsoft at 8000 Avalon
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:05AM CDT
Cousins Properties Incorporated (CUZ) and Hines announced that the global technology major - Microsoft Corp.- has inked a lease deal at 8000 Avalon.
INN: 13.79 (+0.06), WPC: 68.25 (+0.77), CUZ: 11.40 (+0.23), BOXC: 21.89 (-0.05)

Zacks Investment Ideas feature highlights: Vanguard REIT ETF, Apple Hospitality, Brookfield Canada, Summit Hotel and Gaming and Leisure Properties
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:30AM CDT
Zacks Investment Ideas feature highlights: Vanguard REIT ETF, Apple Hospitality, Brookfield Canada, Summit Hotel and Gaming and Leisure Properties
INN: 13.79 (+0.06), APLE: 18.60 (-0.11), VNQ: 90.75 (+0.54), GLPI: 34.76 (+0.14), BOXC: 21.89 (-0.05)

Host Hotels Closes Sale of 3 Non-Core Hotels for $175M
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 6:56AM CDT
Host Hotels & Resorts, Inc. (HST) has made the announcement of closing the sale of three non-core hotels for around $175 million.
INN: 13.79 (+0.06), HST: 17.06 (-0.01), WPC: 68.25 (+0.77), BOXC: 21.89 (-0.05)

4 REITs to Buy Now
Jeremy Mullin - ZACKS - Mon Jun 06, 12:50PM CDT
4 REITs to Buy Now
INN: 13.79 (+0.06), APLE: 18.60 (-0.11), VNQ: 90.75 (+0.54), GLPI: 34.76 (+0.14), BOXC: 21.89 (-0.05)

CorEnergy Infrastructure (CORR) in Focus: Stock Rises 8.2%
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:25AM CDT
CorEnergy Infrastructure Trust, Inc. (CORR) moved big last session, as its shares jumped over 8% on the day.
CORR: 30.04 (-0.36), BOXC: 21.89 (-0.05)

Digital Realty Unveils New Digital Data Centre in Singapore
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 6:55AM CDT
Digital Realty Trust Inc. (DLR) has announced the opening of the new Digital Loyang Way date center in Singapore.
INN: 13.79 (+0.06), DLR: 101.79 (-0.11), WPC: 68.25 (+0.77), BOXC: 21.89 (-0.05)

Lexington Realty Receives Rating Affirmation from Moody's
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:12AM CDT
Ushering in good news for Lexington Realty Trust (LXP), Moody's Investor Service affirmed the company's senior unsecured rating of "Baa2" with a stable outlook.
INN: 13.79 (+0.06), LXP: 10.99 (+0.13), COR: 81.36 (+0.42), BOXC: 21.89 (-0.05)

New Strong Buy Stocks for May 26th
Swarup Gupta - Zacks Investment Research - Thu May 26, 9:25AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
AGR: 42.45 (-0.04), ELLI: 99.81 (+0.21), DF: 16.79 (-0.48), CCU: 20.77 (-1.07), BOXC: 21.89 (-0.05)

Ventas (VTR) Prices $400 Million Senior Notes Offering
Zacks Equity Research - Zacks Investment Research - Thu May 26, 6:31AM CDT
Ventas, Inc. (VTR) announced the pricing of public offering of senior notes of $400 million aggregate principal amount.
INN: 13.79 (+0.06), WPC: 68.25 (+0.77), VTR: 74.18 (+0.10), BOXC: 21.89 (-0.05)

Kilroy Realty (KRC) Rewards Investors with Dividend Hike
Zacks Equity Research - Zacks Investment Research - Mon May 23, 6:57AM CDT
The board of directors of Kilroy Realty Corp. (KRC) announced a 7.1% sequential hike in its quarterly cash dividend.
KRC: 73.73 (+0.85), WSR: 14.84 (+0.20), GLPI: 34.76 (+0.14), BOXC: 21.89 (-0.05)

Terreno Realty Leases 221K Square Feet in New Jersey
Zacks Equity Research - Zacks Investment Research - Thu May 19, 4:12PM CDT
Terreno Realty Corporation (TRNO) has made the announcement of executing a lease deal at an Interstate property in South Brunswick, NJ.
TRNO: 27.43 (+0.25), WSR: 14.84 (+0.20), GLPI: 34.76 (+0.14), BOXC: 21.89 (-0.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

CVS Study: GLP-1 Drugs Effective But Costly

By Hannah Lewis Updated Nov 15, 2026 Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...